StonvexLoading…
StonvexCore line items from BRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $24.91M | $24.61M | $97.03M | $72.74M | $48.30M |
Operating Income | Not available | $-2.39M | $-12.50M | $-9.03M | $-5.68M |
Net Income | Not available | $-2.68M | $-11.95M | $-7.63M | $-4.92M |
EPS (Diluted) | $-0.20 | $-0.14 | $-0.63 | $-0.40 | $-0.26 |
Total Assets | Not available | $698.41M | $709.81M | $714.17M | $699.56M |
Total Liabilities | Not available | $529.25M | $532.61M | $527.51M | $507.51M |
Cash & Equivalents | Not available | $26.90M | $25.14M | $21.11M | $23.64M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 18.00M | 17.92M | 18.03M | 17.98M |